Lineus Medical Awarded Key Patent
By: Lineus Medical
SafeBreak Vascular is a first of its kind breakaway medical device designed for peripheral IV lines. When a damaging level of force is applied to an IV line, SafeBreak Vascular purposefully separates to minimize the effects of the damaging force and to prevent patient bleeding and the spillage of medication. Vance Clement, CEO of Lineus Medical said, "This issuance of this new utility patent is another important step in adding value to our company and protecting our first product to market, SafeBreak Vascular. The portfolio of patents the company has secured puts the company in a strong intellectual property position to protect and defend its value and SafeBreak Vascular from competition."
Spencer Jones, Chief Technology Officer and Founder of Lineus Medical commented, "We continue to build an intellectual property moat around SafeBreak Vascular, and that moat just became more difficult to overcome. Innovation in product design must be accompanied by meaningful patent protection, and we expect that our issued patents and patents currently under review will further protect our technologies and set-us apart for many years in the market place."
ABOUT LINEUS MEDICAL
Lineus Medical is a developer of medical device technologies that serve the vascular access/IV market. The company develops products that help prevent pain and discomfort in patients, save nurses time and control costs for hospitals. SafeBreak Vascular is not yet FDA cleared and is not yet for sale. More information about Lineus Medical is available at www.lineusmed.com.
MKG-0068 Rev 00